An update on the current status and future prospects of erectile dysfunction following radical prostatectomy

Asker H., YILMAZ ORAL D., Oztekin C. V., GÜR S.

PROSTATE, cilt.82, ss.1135-1161, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 82
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1002/pros.24366
  • Dergi Adı: PROSTATE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CAB Abstracts, EMBASE, Gender Studies Database, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.1135-1161
  • Anahtar Kelimeler: cavernous nerve injury, erectile dysfunction, phosphodiesterase type 5 inhibitors, radical prostatectomy, stem cell therapy, CAVERNOUS NERVE INJURY, MESENCHYMAL STEM-CELLS, SHOCK-WAVE THERAPY, DIFFERENTIATION FACTOR-5 THERAPY, TOPICAL ALPROSTADIL CREAM, SOLUBLE GUANYLATE-CYCLASE, RAT MODEL, PENILE REHABILITATION, FUNCTION RECOVERY, VACUUM THERAPY
  • Çukurova Üniversitesi Adresli: Evet

Özet

Background Radical prostatectomy (RP) and radiation treatment are standard options for localized prostate cancer. Even though nerve-sparing techniques have been increasingly utilized in RP, erectile dysfunction (ED) due to neuropraxia remains a frequent complication. Erectile function recovery rates after RP remain unsatisfactory, and many men still suffer despite the availability of various therapies. Objective This systematic review aims to summarize the current treatments for post-RP-ED, assess the underlying pathological mechanisms, and emphasize promising therapeutic strategies based on the evidence from basic research. Method Evaluation and review of articles on the relevant topic published between 2010 and 2021, which are indexed and listed in the PubMed database. Results Phosphodiesterase type 5 inhibitors, intracavernosal and intraurethral injections, vacuum erection devices, pelvic muscle training, and surgical procedures are utilized for penile rehabilitation. Clinical trials evaluating the efficacy of erectogenic drugs in this setting are conflicting and far from being conclusive. The use of androgen deprivation therapy in certain scenarios after RP further exacerbates the already problematic situation and emphasizes the need for effective treatment strategies. Conclusion This article is a detailed overview focusing on the pathophysiology and mechanism of the nerve injury developed during RP and a compilation of various strategies to induce cavernous nerve regeneration to improve erectile function (EF). These strategies include stem cell therapy, gene therapy, growth factors, low-intensity extracorporeal shockwave therapy, immunophilins, and various pharmacological approaches that have induced improvements in EF in experimental models of cavernous nerve injury. Many of the mentioned strategies can improve EF following RP if transformed into clinically applicable safe, and effective techniques with reproducible outcomes.